STEAP1 and cancer: In addition, we investigated the expression differences between six immune subtypes, finding that STEAP1 exerted increased expression in C6 which had the worst survival and decreased expression in C3 which had the optimal prognosis in several cancers such as COAD, LUSC, and STAD, indicating that STEAP1 served as a risk factor in these tumors.